Assignee
STEWARD LANCE E
US·10 granted patents·6 pending applications·132 citations·filing 2006–2012
Top patents by PatentIndex Score
16 records- 0197US8071110B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Dec 6, 2011·32 cites·13 claims
- 0295US8623999B2Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2012·Granted Jan 7, 2014·27 cites·3 claims
- 0394US8128940B2Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2006·Granted Mar 6, 2012·25 cites·5 claims
- 0493US8273358B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Sep 25, 2012·11 cites·9 claims
- 0591US8518417B1Modified clostridial toxins with enhanced translocation capability and enhanced targeting activitySTEWARD LANCE E·Filed 2007·Granted Aug 27, 2013·14 cites·1 claims
- 0691US8273865B2Multivalent clostridial toxinsSTEWARD LANCE E·Filed 2010·Granted Sep 25, 2012·8 cites·13 claims
- 0788US8512992B2Degradable clostridial toxinsSTEWARD LANCE E·Filed 2011·Granted Aug 20, 2013·5 cites·1 claims
- 0886US8460682B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsSTEWARD LANCE E·Filed 2011·Granted Jun 11, 2013·6 cites·13 claims
- 0985US8119767B2Post-translational modifications and clostridial neurotoxinsSTEWARD LANCE E·Filed 2007·Granted Feb 21, 2012·4 cites·1 claims
- 1071US8206723B2Leucine-based motif and clostridial neurotoxinsSTEWARD LANCE E·Filed 2009·Granted Jun 26, 2012·0 cites·4 claims
- 1160US2008032318A1Fret protease assays for clostridial toxinsSTEWARD LANCE E·Filed 2007·Application pending·0 cites
- 1260US2008038756A1Fret protease assays for clostridial toxinsSTEWARD LANCE E·Filed 2007·Application pending·0 cites
- 1355US2010280222A1Clostridial neurotoxin compositions and modified clostridial neurotoxinsSTEWARD LANCE E·Filed 2007·Application pending·0 cites
- 1452US2011294742A1Degradable clostridial toxinsSTEWARD LANCE E·Filed 2011·Application pending·0 cites
- 1550US2012115205A1Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype BsSTEWARD LANCE E·Filed 2010·Application pending·0 cites
- 1650US2008032931A1Activatable clostridial toxinsSTEWARD LANCE E·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →